Hint mode is switched on Switch off

4D Molecular Therapeutics, ordinary share
FDMT, US35104E1001

Add a stock to WL
Choose all Reset all
4D Molecular Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

  • Issuer
  • Full borrower / issuer name
    4D Molecular Therapeutics Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    FDMT
  • Placement
    11.12.2020
  • Lock up period
    180
  • Number of papers
    8,400,000
  • Volume of raised funds
    193.2 mln USD
  • Placement share
    33.29%
  • Final placement price
    23 USD
  • Price change since placement date
    -60.37%
  • By capitalization
    580.38 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    FDMT
  • Placement
    01.11.2021
  • Lock up period
    180
  • Number of papers
    4,750,000
  • Volume of raised funds
    118.75 mln USD
  • Placement share
    15.01%
  • Final placement price
    25 USD
  • Price change since placement date
    -63.54%
  • By capitalization
    791.05 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    FDMT
  • Placement
    08.05.2023
  • Lock up period
    180
  • Number of papers
    40,126,627
  • Volume of raised funds
    120 mln USD
  • Placement share
    18.69%
  • Final placement price
    16 USD
  • Price change since placement date
    -43.03%
  • By capitalization
    642.03 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    FDMT
  • Placement
    06.11.2025
  • Lock up period
    180
  • Number of papers
    8,385,809
  • Volume of raised funds
    88.13 mln USD
  • Placement share
    15.22%
  • Final placement price
    10.51 USD
  • Price change since placement date
    -13.27%
  • By capitalization
    578.95 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2025
I q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
IV q eng
Show all Hide

Related Stock indices

Indicators

News

19/03/2026 4D Molecular Therapeutics Q4 2025 Earnings Exceed Expectations
22/01/2026 4D Molecular Therapeutics: Unregistered Sales Of Equity Securities, Financial Statements And Exhibits
31/12/2025 4D Molecular Therapeutics: Results Of Operations And Financial Condition, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
10/12/2025 4D Molecular Therapeutics: Other Events
17/11/2025 4D Molecular Therapeutics: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
All organization news

Holders

Industry Leaders

Registration is required to get access.